Boston: An Indian-origin researcher in the US has won a grant of USD 150,000 to study a gene mutation linked to a type of deadly skin cancer which has no effective treatment till date.
Skin cancer is the most common of all cancers, and while melanoma is one of the least common types, representing only about 2 per cent of skin cancer cases, it is one of the most deadly.
Some forms of melanoma have no targeted therapy at all. About 20 per cent of melanomas have a mutated gene called NRAS.
Anurag Singh, assistant professor at Boston University in US is tackling this poorly understood melanoma by studying how NRAS transforms healthy, normal skin cells into aggressive cancerous cells.
The work has been funded by a three-year, USD 150,000 grant from the Melanoma Research Alliance.
Mr Singh's lab studies how two forms of the RAS gene, NRAS and KRAS, interact and cooperate with other genes to form gene networks, analogous to computer circuits.
RAS genes belong to a family of molecules called G proteins, which are important for much signalling within human cells.
There are about 200 G proteins of various shapes and sizes, but they all have one thing in common - they can become activated and then, after some period of time, automatically turn themselves off.
Mutant forms of RAS can turn on, but they can't turn off. The mutant RAS is always on, always signalling, even when other signals order it to cease and desist.
This nonstop signalling can lead to different effects - sometimes it makes a cell multiply uncontrollably, sometimes it prevents a cancer cell from self-destructing. This makes the mutant forms of RAS common in cancer.
"The RAS mutation itself is not sufficient to cause a full-blown tumour," said Mr Singh.
"It creates a vulnerable state that can progress to a malignant state," he said.
"We have identified two major types of NRAS networks in melanoma," he said.
"We hypothesise that these subtypes can be treated with selective targeted anticancer agents or precision medicines. We hope to pinpoint vulnerabilities that can be blocked with chemotherapy," he said.
Skin cancer is the most common of all cancers, and while melanoma is one of the least common types, representing only about 2 per cent of skin cancer cases, it is one of the most deadly.
Some forms of melanoma have no targeted therapy at all. About 20 per cent of melanomas have a mutated gene called NRAS.
The work has been funded by a three-year, USD 150,000 grant from the Melanoma Research Alliance.
Advertisement
RAS genes belong to a family of molecules called G proteins, which are important for much signalling within human cells.
Advertisement
Mutant forms of RAS can turn on, but they can't turn off. The mutant RAS is always on, always signalling, even when other signals order it to cease and desist.
Advertisement
"The RAS mutation itself is not sufficient to cause a full-blown tumour," said Mr Singh.
Advertisement
"We have identified two major types of NRAS networks in melanoma," he said.
Advertisement
COMMENTS
Advertisement
India Sends 1,400 kg Anti-Cancer Drugs To Syria In Humanitarian Assistance Hina Khan Sports A Wig, Made Of Her Own Hair, Amid Cancer Battle: " I Am Reunited With My Lost Hair" Shaheer Sheikh Visits "Fearless" Friend Hina Khan In The Hospital. See Post Parents Gave Names Of Interns, Doctors To CBI In Kolkata Horror: Sources How Extreme Weather Is Leading To Rise In Child Marriages In Pakistan Who Is Jasveen Sangha, "Ketamine Queen" Charged With Matthew Perry's Death 20 Coaches Of Sabarmati Express Train Derail In UP, No Casualties Two Sisters Returning From Court Run Over By Car In UP: Cops India Sends 1,400 kg Anti-Cancer Drugs To Syria In Humanitarian Assistance Track Latest News Live on NDTV.com and get news updates from India and around the world.